Catalyst Wire Dossier Catalyst Wire Dossier

Baiya SARS-CoV-2 Vax 2

· Baiya Phytopharm Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Baiya SARS-CoV-2 Vax 2, covering 2023-11-15 to 2023-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19 [Phase 2]

See pricing